February 3, 2025
TOPLINE: Over one third of patients with giant cell arteritis exhibit vascular inflammation even after receiving treatment with tocilizumab and glucocorticoids for at least 6 months, […]
February 3, 2025
The US Food and Drug Administration (FDA) has approved Avtozma (tocilizumab-anoh) as a biosimilar of the original reference biologic tocilizumab (Actemra), according to a January 30 […]
January 30, 2025
Biosimilars are often promoted as cost-saving alternatives to their reference medications. Designed to provide comparable therapeutic efficacy at a reduced price, they have the potential to […]
January 30, 2025
TOPLINE: Discontinuing adalimumab increases relapse rates in patients with juvenile idiopathic arthritis (JIA)–associated uveitis. However, patients can regain inflammation control after resuming the treatment. METHODOLOGY: Researchers […]
January 30, 2025
TOPLINE: The positive predictive value (PPV) of myositis antibodies for diagnosing myositis and its related conditions differs by individual antibody type. Greater diagnostic accuracy is associated […]
January 27, 2025
TOPLINE: Large language models (LLMs) perform differently in answering rheumatology questions, with ChatGPT-4 demonstrating higher accuracy and quality than Gemini Advanced and Claude 3 Opus. However, […]
January 24, 2025
Earlier this month, the US Preventive Services Task Force (USPSTF) released updated screening recommendations for osteoporosis. The task force reaffirmed their 2018 recommendations that all women […]
January 22, 2025
TOPLINE: According to a recent study on patient and clinician perspective on the different aspects of psoriatic arthritis (PsA) care, patients and clinicians agree on core […]
January 22, 2025
Baricitinib can effectively treat polymyalgia rheumatica (PMR) without the use of oral glucocorticoids, according to results from a small, randomized, double-blind, placebo-controlled study. Among the 18 […]